The meta-analysis claims, "The level of protection against re-infection, symptomatic disease, and severe disease appears to be at least as durable, if not more so, than that provided by two-dose vaccination with the mRNA vaccines."
The Biden administration, through Delaware U.S. Attorney David Weiss, filed a statement of interest in a case alleging Moderna stole intellectual property from biotech companies Arbutus and Genevant.
A recent medical report has identified the self-limited occurrence of gross hematuria (blood in urine) in two elderly men who were on a combination of aspirin and another antiplatelet or anticoagulant following their second dose of the Moderna COVID-19 vaccination.
A case report in the medical journal Frontiers in Immunology highlights a rare case of a patient developing rheumatoid encephalitis after receiving a booster immunization of the mRNA-1273 COVID-19 vaccine, raising concerns about potential adverse reactions to the vaccine.
A new preprint by Wilson N. Sy, PhD, Director of the Biotechnology Unit at Investment Analytics Research located in Australia, finds that excess deaths in Australia in 2021 were likely due to vaccination, not COVID-19 mortality.